| 1.5 |
4.4 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 1.5 |
4.4 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 1.0 |
5.0 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.8 |
3.4 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.8 |
1.6 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) |
| 0.8 |
4.8 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.8 |
2.4 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.7 |
2.0 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.7 |
3.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.7 |
2.0 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 0.6 |
1.9 |
GO:0042939 |
renal sodium ion transport(GO:0003096) glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.5 |
1.5 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 |
5.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.4 |
1.3 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 |
1.7 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.4 |
0.4 |
GO:0046544 |
development of secondary male sexual characteristics(GO:0046544) |
| 0.4 |
1.6 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.4 |
2.4 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.4 |
2.0 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.4 |
1.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.3 |
1.0 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.3 |
1.6 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.3 |
4.1 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 |
1.2 |
GO:0002606 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.3 |
0.9 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 |
4.8 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.3 |
1.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
2.0 |
GO:2000822 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.3 |
2.3 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.3 |
2.6 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.3 |
0.8 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.3 |
1.1 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.2 |
1.0 |
GO:0061113 |
positive regulation of hh target transcription factor activity(GO:0007228) astrocyte activation(GO:0048143) pancreas morphogenesis(GO:0061113) metanephric renal vesicle formation(GO:0072093) |
| 0.2 |
0.7 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 |
1.4 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
0.7 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.2 |
1.5 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.2 |
1.3 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
1.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
1.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
1.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
0.8 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 |
0.2 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.2 |
2.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
0.6 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 0.2 |
5.1 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.2 |
1.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.2 |
0.6 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
0.7 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
1.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
1.6 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 |
1.7 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.2 |
0.3 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.2 |
1.0 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
0.6 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
1.5 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
0.6 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.2 |
0.5 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
1.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
1.0 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
1.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.7 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.7 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.3 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.1 |
2.5 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.4 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.1 |
0.5 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
0.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.9 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.1 |
1.7 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.5 |
GO:0061428 |
embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.4 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
1.4 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.1 |
0.6 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.4 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.1 |
0.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
3.6 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
4.0 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.9 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.5 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
1.0 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
0.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
0.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.7 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
1.7 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
0.4 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.6 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.7 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.4 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.1 |
0.2 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) |
| 0.1 |
0.4 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.8 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.1 |
0.4 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.3 |
GO:0002586 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.3 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.1 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
1.6 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
8.3 |
GO:0048709 |
oligodendrocyte differentiation(GO:0048709) |
| 0.1 |
0.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.5 |
GO:0061643 |
chemorepulsion of axon(GO:0061643) |
| 0.1 |
0.5 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
0.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) regulation of vascular wound healing(GO:0061043) |
| 0.1 |
0.6 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
0.4 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.5 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
1.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
1.9 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
1.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
1.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.4 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.7 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.2 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
0.3 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 |
0.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.3 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
1.2 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.4 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.8 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
1.0 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.8 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.6 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.3 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.8 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.9 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.6 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.8 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
6.6 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.1 |
0.8 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.1 |
0.3 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
3.7 |
GO:0007173 |
epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 |
0.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.6 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 |
0.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
1.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
3.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.5 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.1 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.0 |
0.3 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.0 |
0.8 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
1.0 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.3 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.0 |
0.1 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 |
0.1 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.5 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.0 |
0.3 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.1 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.0 |
0.4 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.0 |
0.1 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.0 |
0.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.2 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.0 |
0.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.3 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
1.3 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.6 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.8 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.0 |
0.5 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.4 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.4 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.7 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
1.2 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
1.1 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.0 |
0.6 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.0 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.8 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.8 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.1 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) endothelial cell fate commitment(GO:0060839) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.5 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 |
0.2 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.2 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.1 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 |
0.8 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.4 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.3 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.2 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.0 |
0.2 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.4 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.7 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.8 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.0 |
0.2 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.0 |
0.8 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
1.5 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.0 |
0.2 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.3 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.5 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.0 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.0 |
0.0 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.7 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.1 |
GO:1990182 |
exosomal secretion(GO:1990182) |
| 0.0 |
0.3 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
0.1 |
GO:2000643 |
positive regulation of vacuolar transport(GO:1903337) positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.0 |
0.1 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.0 |
0.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.3 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.4 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 |
0.2 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.1 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.6 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.5 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.4 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.4 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.0 |
0.1 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
0.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.0 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) voluntary musculoskeletal movement(GO:0050882) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.0 |
0.2 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
